Accéder au contenu
Merck

A post-insertion strategy for surface functionalization of bacterial and mammalian cell-derived extracellular vesicles.

Biochimica et biophysica acta. General subjects (2020-10-17)
Linglei Jiang, Joen Luirink, Sander A A Kooijmans, Kok P M van Kessel, Wouter Jong, Max van Essen, Cor W Seinen, Steven de Maat, Olivier G de Jong, Jerney F F Gitz-François, Wim E Hennink, Pieter Vader, Raymond M Schiffelers
RÉSUMÉ

Extracellular vesicles (EVs) are nanoparticles which are released by cells from all three domains of life: Archaea, Bacteria and Eukarya. They can mediate cell-cell communication by transferring cargoes such as proteins and nucleic acids between cells. EVs receive great interest in both academia and industry as they have the potential to be natural drug carriers or vaccine candidates. However, limitations to their clinical translation exist as efficient isolation, loading, labelling and surface-engineering methods are lacking. In this article, we investigate a 'post-insertion' approach, which is commonly used in the functionalization of liposomes in the pharmaceutical field, on two different EV types: mammalian cell-derived EVs and bacteria-derived EVs. We aimed to find an easy and flexible approach to functionalize EVs, thereby improving the labelling, isolation, and surface-engineering.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Monoclonal Anti-Folic Acid antibody produced in mouse, clone VP-52, ascites fluid